HIF targets in bone remodeling and metastatic disease.

Johnson RW, Schipani E, Giaccia AJ
Pharmacol Ther. 2015 150: 169-77

PMID: 25681658 · PMCID: PMC4414805 · DOI:10.1016/j.pharmthera.2015.02.002

MeSH Terms (11)

Antineoplastic Agents Bone Development Bone Neoplasms Bone Remodeling Cell Hypoxia Humans Hypoxia-Inducible Factor 1 Molecular Targeted Therapy Prolyl Hydroxylases Tumor Microenvironment Von Hippel-Lindau Tumor Suppressor Protein

Connections (1)

This publication is referenced by other Labnodes entities:

Links